P29HMW8R7FGU
Saturday, March 5, 2011
Subscribe to:
Post Comments (Atom)
Popular Posts
-
The Government may soon ban the controversial anti-anxiety drug Deanxit, a combination of two psycho-active agents being frequently pr... -
To, The Editor, Clinical Research News Sir, I am writing this letter in connection with the recent ban of human placenta extract as a drug ...
-
CorMedix Inc. ("CorMedix") , a pharmaceutical company focused on developing and commercializing therapeutic products for the p... -
The Gujarat Food & Drugs Control Administration (FDCA) is stepping up its efforts to stop manufacturing of six drugs recently bann... -
Randomization and blinding are critical components of the clinical trial from the start (design) to the end. Randomized, controlled, an... -
Halozyme Therapeutics, Inc. (Nasdaq: HALO) announced the initiation of two Phase 2 Ultrafast Insulin treatment studies that utilize its rH... -
The U.S. Food and Drug Administration today announced approval of the first rapid blood test for antibodies to the hepatitis C virus (HC... -
Cubist Pharmaceuticals, a leading acute care therapeutics company, announced the enrollment of the first patient in a Phase 2 study with C... -
Pfizer Inc has suspended its clinical trials of the experimental osteoarthritis drug tanezumab effective immediately after finding that ... -
Enzo Biochem, Inc. announced that, following filing of a investigational new drug (IND) application with the FDA, its Enzo ...
